Examine This Report on Relacorilant
STAR-0310 STAR-0310 can be a novel OX40 antagonistic monoclonal antibody that has a potential ideal-in-course profile that has a high affinity, potential for favorable protection and tolerability profile with small T cell depletion from ADCC or possible on-goal mobile toxicity.and better levels of toxin expression as a result of dominance of CodY-u